Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Parallel-group, Intervention Study to Assess At-home, Game-based Digital Therapy for Treating Pediatric Participants Ages 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)

NCT02674633 is registered in ClinicalTrials.gov with Akili Interactive Labs, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Parallel-group, Intervention Study to Assess At-home, Game-based Digital Therapy for Treating Pediatric Participants Ages 8 to 12 Years Old With Attention Deficit Hyperactivity Disorder (ADHD)
Lead sponsor
Akili Interactive Labs, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2016
Completion date
August 31, 2017
Enrollment
348 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.